Traditional Chinese medicine for treating keratoconjunctivitis sicca and preparation method thereof

Abstract

The invention provides a Chinese medicinal composition for treating keratoconjunctivitis sicca, which comprises the following raw material drugs: heartleaf houttuynia herb, dendrobe, mulberry leaf, medlar, yerbadetajo herb, cassia seed, multiflower knotweed vine, red bean, mulberry, kamuning, liriope spicata, America ginseng, plantain herb, fragrant solomonseal rhizome, figwort root, raw rehmannia, coral ardisia root, buerger pipewort flower, papermulberry fruit, motherwort and liquorice. Compared with a western medicament, the Chinese medicinal composition has good curative effect, relapse prevention, small toxic and side effects and low residue rate in treating keratoconjunctivitis sicca, can regulate a whole human body to achieve the effect of treating both principal and secondary aspect of disease, and is a safe and reliable Chinese medicament for treating keratoconjunctivitis sicca with remarkable curative effect.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine for treating keratoconjunctival xerosis and a preparation method thereof. Background technique [0002] Keratoconjunctivitis sicca, also known as keratoconjunctivitis sicca and dry eye, is the most common clinical chronic ocular surface disease, which refers to the abnormal tear quality and quantity caused by various reasons, or abnormal tear fluid dynamics. A group of disorders in which tear film instability and ocular surface damage lead to ocular discomfort. Clinical manifestations include eye dryness, foreign body sensation, burning sensation, itching, vision fluctuations, blurred vision, red eyes, photophobia, and visual fatigue. With the change of people's living habits and working environment, the incidence of keratoconjunctiva sicca is getting higher and higher. In the United States, 14.16% of people over 65 years old s...

AI Technical Summary

Problems solved by technology

[0004] At present, there is no particularly effective treatment for keratoconjunctival sicca. The principle of western medicine treatment for keratoconjunctiva sicca is to supplement artificial tears, stimulate tear secretion, and reduce tear loss. The main methods are: eye drops with artificial tears, wearing hydrophilic soft cornea Contact lenses, blocked or closed puncta, use of drugs to stimulate lacrimal secretion, etc. For mild and moderate patients, supplementary artificial tears are often used for symptomatic treatment. In addition to the above measures, severe patients are given punctal plugs, anti-inflammatory, immunosuppressants or surgery. , these are limited to the adjustment of the local state of the ocular surface, and eye drops are not vitamins, nor are they eye-care solutions. Abuse of eye drops will cause problems such as drug durability or adverse reactions. Long-term use is likely to damage the conjunctival microcells, accessory lacrimal gland etc. cause damage, but aggravate the symptoms of keratoconjunctival sicca, which is not conducive to the fundamental improvement of keratoconjunctival sicca, and has various disadvantages and inconveniences.